randomized sixty-nine patients with PD to a multi-strain probiotic or placebo, and after twelve weeks, patients taking the probiotic had lower inflammatory markers such as c reactive protein (CRP) and better metabolic profiles such as lower insulin resistance. This evidence concerns the gene CRP and Insulin resistance.